Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
Author(s):
Meijer, T.S.; Burgmans, M.C.; Fiocco, M.; Geus-Oei, L.F. de; Kapiteijn, E.; Leede, E.M. de; Martini, C.H.; Meer, R.W. van der; Tijl, F.G.J.; Vahrmeijer, A.L.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019
Language
English
Is part of
CardioVascular and Interventional Radiology (2019), Vol. 42, no. 6, p. 841-852
